{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:39:38Z","timestamp":1792521578466,"version":"4.5.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Li-Fraumeni syndrome (LFS) is an inherited cancer predisposition syndrome caused by germline TP53 mutations and is associated with an increased risk of several malignancies. Although breast implant\u2013associated anaplastic large cell lymphoma has been reported in patients with LFS, primary cutaneous anaplastic large cell lymphoma has not previously been described. We report a case of primary cutaneous anaplastic large cell lymphoma in a 64-year-old man with LFS harboring a germline TP53 p.R196* mutation who presented with a solitary ulcerated nodule on the left anterior thigh. Histopathologic examination demonstrated an ulcerated dermal infiltrate of large atypical CD30-positive T lymphocytes admixed with small lymphocytes and eosinophils. Immunophenotyping showed expression of CD3, CD2, CD4, CD30, CD43, and CD45, with weak CD5 expression and loss of CD7 and EMA. Targeted exome sequencing identified the patient's known germline TP53 mutation together with additional somatic mutations and copy number alterations, whereas whole-body positron emission tomography\/computed tomography demonstrated no evidence of systemic disease. The lesion was completely excised, and radiotherapy was deferred because of the patient's underlying LFS and associated risk of radiation-induced malignancy. The patient remains disease-free 36 months after diagnosis. This case expands the spectrum of lymphoid malignancies reported in patients with LFS and highlights the importance of recognizing hereditary cancer predisposition syndromes when selecting treatment strategies for primary cutaneous lymphomas.<\/jats:p>","DOI":"10.1097\/dad.0000000000003398","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:00:30Z","timestamp":1785790830000},"page":"e119-e122","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Primary Cutaneous Anaplastic Large Cell Lymphoma in a Patient With Li Fraumeni Syndrome"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5252-3039","authenticated-orcid":false,"given":"Aliya","family":"Shabbir","sequence":"first","affiliation":[{"name":"Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Awh","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;"},{"name":"Case Western Reserve University School of Medicine, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia S.","family":"DeSimone","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jacobsen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Larocca","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"R1-20261020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrclinonc.2014.41","article-title":"Li-Fraumeni syndrome: cancer risk assessment and clinical management","volume":"11","author":"McBride","year":"2014","journal-title":"Nat Rev Clin Oncol."},{"key":"R2-20261020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13000-018-0688-x","article-title":"Breast implant-associated anaplastic large cell lymphoma in a Li-Fraumeni patient: a case report","volume":"13","author":"Pastorello","year":"2018","journal-title":"Diagn Pathol."},{"key":"R3-20261020","first-page":"5647940","article-title":"Increasing evidence for the Association of Breast Implant-associated anaplastic large cell lymphoma and Li fraumeni syndrome","volume":"2019","author":"Adlard","year":"2019","journal-title":"Case Rep Genet."},{"key":"R4-20261020","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni syndrome from TP53 mutation carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"J Clin Oncol."},{"key":"R5-20261020","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/jamaoncol.2021.4398","article-title":"Analysis of the Li-Fraumeni spectrum based on an international germline TP53 variant data set: an international agency for research on cancer TP53 database analysis","volume":"7","author":"Kratz","year":"2021","journal-title":"JAMA Oncol."},{"key":"R6-20261020","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"key":"R7-20261020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00428-023-03676-6","article-title":"Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas","volume":"485","author":"de Haan","year":"2024","journal-title":"Virchows Arch."},{"key":"R8-20261020","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1097\/MPH.0000000000000948","article-title":"Nodular lymphocyte-predominant Hodgkin lymphoma in a 15-year-old boy with Li-Fraumeni syndrome having a germline TP53 D49H mutation","volume":"40","author":"Yamazaki","year":"2018","journal-title":"J Pediatr Hematol Oncol."},{"key":"R9-20261020","doi-asserted-by":"crossref","first-page":"e17929","DOI":"10.7554\/eLife.17929","article-title":"TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions","volume":"5","author":"Shirole","year":"2016","journal-title":"Elife"},{"key":"R10-20261020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13053-023-00272-2","article-title":"Li-Fraumeni syndrome presenting with de novo TP53 mutation, severe phenotype and advanced paternal age: a case report","volume":"22","author":"Arango-Iba\u00f1ez","year":"2024","journal-title":"Hered Cancer Clin Pract."},{"key":"R11-20261020","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41418-022-00976-3","article-title":"The TP53 database: transition from the international agency for research on cancer to the US national cancer Institute","volume":"29","author":"de Andrade","year":"2022","journal-title":"Cell Death Differ."},{"key":"R12-20261020","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3324\/haematol.2020.263251","article-title":"Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma","volume":"107","author":"Bastidas Torres","year":"2022","journal-title":"Haematologica"},{"key":"R13-20261020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00428-019-02570-4","article-title":"Systemic, primary cutaneous, and breast implant-associated ALK-negative anaplastic large-cell lymphomas present similar biologic features despite distinct clinical behavior","volume":"475","author":"Gerbe","year":"2019","journal-title":"Virchows Arch."},{"key":"R14-20261020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.humpath.2017.01.003","article-title":"Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping","volume":"64","author":"Wang","year":"2017","journal-title":"Hum Pathol."},{"issue":"suppl 1","key":"R15-20261020","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2019-126501","article-title":"Analysis of mutational landscape in systemic Anaplastic large cell lymphoma identifies novel Prognostic markers","volume":"134","author":"Lobello","year":"2019","journal-title":"Blood"},{"key":"R16-20261020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.21037\/atm-20-7574","article-title":"Molecular profiling of Chinese systemic anaplastic large cell lymphoma patients: novel evidence of genetic heterogeneity","volume":"9","author":"Zhong","year":"2021","journal-title":"Ann Transl Med."},{"key":"R17-20261020","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41375-020-01093-1","article-title":"STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma","volume":"35","author":"Lobello","year":"2021","journal-title":"Leukemia"},{"key":"R18-20261020","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood-2013-10-534693","article-title":"SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003398","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:00:13Z","timestamp":1792519213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003398","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}